BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$903M |
| 2 |
Apple
AAPL
|
+$854M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$771M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$696M |
| 5 |
Oracle
ORCL
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$1.55B |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$976M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$928M |
| 4 |
AET
Aetna Inc
AET
|
+$832M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.45% |
| 2 | Technology | 14.96% |
| 3 | Healthcare | 12.92% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGNX
2176
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $59.5M | ﹤0.01% |
9,996,741
+202,932
| +2% | +$1.23M |
|
|
HSII
2177
DELISTED
Heidrick & Struggles
HSII
| $59.3M | ﹤0.01% |
2,414,523
+35,124
| +1% | +$823K |
|
2178
abrdn Physical Palladium Shares ETF
PALL
$662M
| $59.1M | ﹤0.01% |
2,908,605
-383,770
| -12% | -$7.28M |
|
|
DENN
2179
DELISTED
Denny's
DENN
| $59M | ﹤0.01% |
4,458,799
-11,469
| -0.3% | -$149K |
|
|
FBC
2180
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $59M | ﹤0.01% |
1,577,291
-21,256
| -1% | -$780K |
|
2181
Cytokinetics
CYTK
$11B
| $59M | ﹤0.01% |
7,239,394
+393,494
| +6% | +$4.47M |
|
2182
DXP Enterprises
DXPE
$3.07B
| $59M | ﹤0.01% |
1,994,404
+13,861
| +0.7% | +$403K |
|
2183
IMAX
IMAX
$2.73B
| $58.9M | ﹤0.01% |
2,543,954
+31,318
| +1% | +$738K |
|
2184
Forrester Research
FORR
$233M
| $58.9M | ﹤0.01% |
1,331,814
+75,907
| +6% | +$3.41M |
|
|
AVP
2185
DELISTED
Avon Products, Inc.
AVP
| $58.7M | ﹤0.01% |
27,287,133
-1,041,013
| -4% | -$2.24M |
|
|
COUP
2186
DELISTED
Coupa Software Incorporated
COUP
| $58.6M | ﹤0.01% |
1,878,010
+22,441
| +1% | +$762K |
|
2187
iShares Floating Rate Bond ETF
FLOT
$10.3B
| $58.6M | ﹤0.01% |
1,152,518
-110,192
| -9% | -$5.61M |
|
|
CCRN
2188
DELISTED
Cross Country Healthcare
CCRN
| $58.5M | ﹤0.01% |
4,588,476
+204,515
| +5% | +$2.7M |
|
2189
Huron Consulting
HURN
$2.39B
| $58.4M | ﹤0.01% |
1,444,220
-86,797
| -6% | -$3.33M |
|
2190
Stock Yards Bancorp
SYBT
$2.61B
| $58.1M | ﹤0.01% |
1,541,618
+18,775
| +1% | +$720K |
|
2191
Akebia Therapeutics
AKBA
$264M
| $58.1M | ﹤0.01% |
3,905,506
+152,402
| +4% | +$2.53M |
|
|
ITCI
2192
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $58M | ﹤0.01% |
4,002,920
+709,048
| +22% | +$10.9M |
|
2193
BancFirst
BANF
$3.81B
| $57.9M | ﹤0.01% |
1,131,701
+22,802
| +2% | +$1.26M |
|
|
XOXO
2194
DELISTED
Xo Group Inc
XOXO
| $57.6M | ﹤0.01% |
3,120,525
+2,769
| +0.1% | +$53.8K |
|
|
LBAI
2195
DELISTED
Lakeland Bancorp Inc
LBAI
| $57.5M | ﹤0.01% |
2,989,563
+57,104
| +2% | +$1.16M |
|
|
CRC
2196
DELISTED
California Resources Corporation
CRC
| $57.5M | ﹤0.01% |
2,959,318
+40,990
| +1% | +$575K |
|
|
POT
2197
DELISTED
Potash Corp Of Saskatchewan
POT
| $57.5M | ﹤0.01% |
2,783,290
-237,399
| -8% | -$4.6M |
|
|
AFSI
2198
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $57.4M | ﹤0.01% |
5,703,727
+1,550
| +0% | +$17.6K |
|
|
WEB
2199
DELISTED
Web.com Group, Inc.
WEB
| $57.4M | ﹤0.01% |
2,633,177
-85,385
| -3% | -$2M |
|
2200
Team
TISI
$77.8M
| $57.3M | ﹤0.01% |
384,318
+18,340
| +5% | +$2.44M |
|
Similar funds
BlackRock's Q4 2017 Portfolio in Review
As of Q4 2017, BlackRock held 5,151 positions worth $2.1T, up 6.1% from $1.98T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BlackRock's Q4 2017 filing shows 147 new, 3,054 increased, 1,214 reduced and 177 closed positions. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M. The largest sale was CR Bard Inc., an estimated $1.55B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- BlackRock's largest Q4 2017 buy was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M.
- BlackRock added most to Meta Platforms (Facebook) in Q4 2017, an estimated $903M increase.
- BlackRock's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $928M.
- BlackRock fully exited CR Bard Inc. in Q4 2017, selling an estimated $1.55B.
- BlackRock's ten largest holdings make up 13% of its $2.1T portfolio in Q4 2017.
- BlackRock opened 147 new positions and closed 177 in Q4 2017.
- BlackRock's portfolio value rose 6.1% quarter-over-quarter to $2.1T.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.